Barcelona Science Park presents the Exporecerca Jove awards Blog Post

From 28 February to 2 March the YoMo Festival in La Farga de l’Hospitalet hosted the 20th Exporecerca Jove, a fair featuring 120 research projects by young people aged 12 to 30. The exhibition is organised every year by the MAGMA association. The idea is to encourage young people to get involved in research, promote sharing experiences and drive participation at this and other fairs and congresses in Spain and abroad. The Barcelona Science Park (Parc Científic de Barcelona, PCB) handed out three awards and a runner-up prize consisting of a day in a laboratory at its facilities along with the chance to attend a workshop in its Research in Society programme.

 

Urea-powered nanomotors a promising therapy for bladder cancer Blog Post

The Smart Nano-Bio-Devices group at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park have published a paper describing nanomotors that can attack 3D bladder cancer spheroids in vitro. The study reveals that nanomotors are a promising way to specifically target tumor tissues, enhancing the efficacy of cancer treatment and minimizing side effects.

 

Launch of “StarLife”, a new informatics infrastructure to boost biomedical research Blog Post

Today marks the official presentation of “StarLife”, an informatics cluster that is housed at the Barcelona Supercomputing Center. This infrastructure is designed to give impetus and service to biomedical research of excellence and precision medicine. A joint initiative of the Institute for Research in Biomedicine (IRB Barcelona) based in the Barcelona Science Park, the Barcelona Supercomputing Center – Centro Nacional de Supercomputación (BSC-CNS) and the Centre for Genomic Regulation (CRG). StarLife is funded by the Catalan Government –through the ERDF– and ”la Caixa”.

 

Aromics recieves 1 M€ from the European Union to boost its drug against the asbestos-related hallmark cancer Blog Post

Aromics, a biotech company located at the Barcelona Science Park (PCB), has been awarded with 1,085.659€ from the European Union – through the SME instrument of the Horizon 2020 (H2020-EIC-SMEInst-2018-2020-Phase 2)– for the development of the BERMES project, whose objective is the completion of the regulatory preclinics of NAX035, an innovative therapy for the treatment of malignant mesothelioma, an aggressive and highly refractory tumor directly related to asbestos exposure.

 

Joan J. Guinovart awarded with the Royal Academy of Pharmacy of Catalonia Prize Blog Post

Joan J. Guinovart was awarded XXII Prize from the Royal Academy of Pharmacy of Catalonia in recognition of his significant contribution to the field of pharmacy in Catalonia, as well as in Spain and the rest of the world. Guinovart served as the first director of the Institute for Research in Biomedicine (IRB Barcelona) and is the group leader of the Metabolic Engineering and Diabetes Therapy lab at the same institute based in PCB.

 

Defective glial cells can push neurons toward Parkinson’s disease Blog Post

Defective versions of human brain cells called astrocytes are linked to the buildup of a toxic protein that is one the hallmarks of Parkinson’s disease. This is one of the main conclusions of a study led by Antonella Consiglio, researcher at the Institute of Biomedicine of the University of Barcelona (IBUB) in the Barcelona Science Park, and the Bellvitge Biomedical Research Institute (IDIBELL), and Àngel Raya, from the Center of Regenerative Medicine in Barcelona (CMR[B]-IDIBELL).

 

Researchers at IRB Barcelona develop a tool to tackle resistance in cancer Blog Post

The lab headed by Modesto Orozco at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park has developed a tool to tackle resistance in cancer. The therapeutic approach has been validated in breast cancer cells in vitro, and the results have been published in the scientific journal Chemical Communications.

 

Proteins can transfer electrons at a distance Blog Post

Researchers from the Institute for Bioengineering of Catalonia (IBEC) al PCB have published a study in Nature Communications that reveals that electron transfer can take place while a protein is approaching its partner site, and not only when the proteins are engaged, as was previously thought. The results open up a new way of thinking about how proteins interact, and can have implications in a better understanding of many processes – such as photosynthesis, respiration and detoxification – in which electron transfer plays an important role.